Patent · US Expired

Substituted quinazolinones for treating neurological conditions

US8084459B2 · kind B2 · utility

36Cited by

2References

5Claims

0Family size

Assignee

Prana Biotechnology Limited · AU

Inventors

Gaik Beng Kok · Melbourne, AU
Brenda Kwan Yi Leung · Melbourne, AU

Key dates

Filing date	Apr 1, 2005
Grant date	Dec 27, 2011
Priority date	—
Expiry date	Jul 13, 2025

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds of the formulaor salts, tautomers or isomers thereof, are useful for treating neurological conditions, especially neurodegenerative disorders, such as Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.